✦ LIBER ✦

Phase II Trial of Weekly Intravenous Gemcitabine Administration With Interferon and Interleukin-2 Immunotherapy for Metastatic Renal Cell Cancer

✍ Scribed by Neri, B.; Doni, L.; Gemelli, M.T.; Fulignati, C.; Turrini, M.; Di Cello, V.; Dominici, A.; Maleci, M.; Mottola, A.; Ponchietti, R.; Raugei, A.; Valsuani, G.; Cini, G.

Book ID: 122966397
Publisher: Lippincott Williams and Wilkins
Year: 2002
Tongue: English
Weight: 118 KB
Volume: 168
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)64550-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of intravenous gemcitab

A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma

✍ Christopher W. Ryan; Nicholas J. Vogelzang; Walter M. Stadler 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to determine the response rate and toxicity of gemcitabine and continuous‐infusion 5‐fluorouracil (5‐FU) in combination with subcutaneous interleukin‐2 (IL2) and interferon‐α (IFNA) in patients with metastatic renal cell carcinoma. ## METH

Phase III, randomised, multicentre trial

Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer

✍ Rodolfo Passalacqua; Carlo Buzio; Sebastiano Buti; Camillo Porta; Roberto Labian 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 284 KB

A Phase II Trial of Gemcitabine Plus Cap

A Phase II Trial of Gemcitabine Plus Capecitabine for Metastatic Renal Cell Cancer Previously Treated With Immunotherapy and Targeted Agents

✍ Tannir, Nizar M.; Thall, Peter F.; Ng, Chaan S.; Wang, Xuemei; Wooten, Leiko; Si 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 118 KB

Sequential administration of interferon

Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial

✍ Manuela Schmidinger; Günther G. Steger; Catharina Wenzel; Gottfried J. Locker; T 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 111 KB

Phase II trial of 5-fluorouracil, interf

Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma

✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d

Phase II trial of interleukin 2, interfe

Phase II trial of interleukin 2, interferon α, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.

✍ JP Dutcher; T Logan; M Gordon; J Sosman; G Weiss; K Margolin; T Plasse; J Mier; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 72 KB